Literature DB >> 30740407

Lysosomal storage disease overview.

Angela Sun1.   

Abstract

The lysosomal storage diseases (LSDs) are a group of inherited metabolic disorders that are caused for the most part by enzyme deficiencies within the lysosome resulting in accumulation of undegraded substrate. This storage process leads to a broad spectrum of clinical manifestations depending on the specific substrate and site of accumulation. Examples of LSDs include the mucopolysaccharidoses, mucolipidoses, oligosaccharidoses, Pompe disease, Gaucher disease, Fabry disease, the Niemann-Pick disorders, and neuronal ceroid lipofuscinoses. This review summarizes the main clinical features, diagnosis, and management of LSDs with an emphasis on those for which treatment is available.

Entities:  

Keywords:  Fabry; Gaucher; Lysosomal storage disease (LSD); Niemann-Pick; mucopolysaccharidosis (MPS)

Year:  2018        PMID: 30740407      PMCID: PMC6331358          DOI: 10.21037/atm.2018.11.39

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  91 in total

1.  Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course.

Authors:  Mary H Branton; Raphael Schiffmann; Sharda G Sabnis; Gary J Murray; Jane M Quirk; Gheona Altarescu; Lev Goldfarb; Roscoe O Brady; James E Balow; Howard A Austin Iii; Jeffrey B Kopp
Journal:  Medicine (Baltimore)       Date:  2002-03       Impact factor: 1.889

2.  The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.

Authors:  J Charrow; H C Andersson; P Kaplan; E H Kolodny; P Mistry; G Pastores; B E Rosenbloom; C R Scott; R S Wappner; N J Weinreb; A Zimran
Journal:  Arch Intern Med       Date:  2000-10-09

Review 3.  Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations.

Authors:  Joel Charrow; Hans C Andersson; Paige Kaplan; Edwin H Kolodny; Pramod Mistry; Gregory Pastores; Ainu Prakash-Cheng; Barry E Rosenbloom; C Ronald Scott; Rebecca S Wappner; Neal J Weinreb
Journal:  J Pediatr       Date:  2004-01       Impact factor: 4.406

4.  Sleep disturbance in mucopolysaccharidosis type III (Sanfilippo syndrome): a survey of managing clinicians.

Authors:  J Fraser; J E Wraith; M B Delatycki
Journal:  Clin Genet       Date:  2002-11       Impact factor: 4.438

5.  Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.

Authors:  V Koprivica; D L Stone; J K Park; M Callahan; A Frisch; I J Cohen; N Tayebi; E Sidransky
Journal:  Am J Hum Genet       Date:  2000-05-04       Impact factor: 11.025

6.  Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease.

Authors:  D Elstein; C Hollak; J M F G Aerts; S van Weely; M Maas; T M Cox; R H Lachmann; M Hrebicek; F M Platt; T D Butters; R A Dwek; A Zimran
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 7.  Genotype and phenotype in Fabry disease: analysis of the Fabry Outcome Survey.

Authors:  E Schaefer; A Mehta; A Gal
Journal:  Acta Paediatr Suppl       Date:  2005-03

8.  Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry.

Authors:  Neal J Weinreb; Joel Charrow; Hans C Andersson; Paige Kaplan; Edwin H Kolodny; Pramod Mistry; Gregory Pastores; Barry E Rosenbloom; C Ronald Scott; Rebecca S Wappner; Ari Zimran
Journal:  Am J Med       Date:  2002-08-01       Impact factor: 4.965

Review 9.  Therapeutic goals in the treatment of Gaucher disease.

Authors:  Gregory M Pastores; Neal J Weinreb; Hans Aerts; Generoso Andria; Timothy M Cox; Manuel Giralt; Gregory A Grabowski; Pramod K Mistry; Anna Tylki-Szymańska
Journal:  Semin Hematol       Date:  2004-10       Impact factor: 3.851

10.  Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey.

Authors:  A Mehta; R Ricci; U Widmer; F Dehout; A Garcia de Lorenzo; C Kampmann; A Linhart; G Sunder-Plassmann; M Ries; M Beck
Journal:  Eur J Clin Invest       Date:  2004-03       Impact factor: 4.686

View more
  49 in total

1.  A kinase cascade on the yeast lysosomal vacuole regulates its membrane dynamics: conserved kinase Env7 is phosphorylated by casein kinase Yck3.

Authors:  Surya P Manandhar; Ikha M Siddiqah; Stephanie M Cocca; Editte Gharakhanian
Journal:  J Biol Chem       Date:  2020-07-09       Impact factor: 5.157

2.  Neurocognitive functioning in long-term survivors of pediatric hematopoietic cell transplantation.

Authors:  Kendra R Parris; Kathryn M Russell; Brandon M Triplett; Sean Phipps
Journal:  Bone Marrow Transplant       Date:  2020-11-14       Impact factor: 5.483

3.  Selective Lysosome Membrane Turnover Is Induced by Nutrient Starvation.

Authors:  Chan Lee; Lilian Lamech; Eleanor Johns; Michael Overholtzer
Journal:  Dev Cell       Date:  2020-09-10       Impact factor: 12.270

Review 4.  Drug Treatment of Progressive Myoclonic Epilepsy.

Authors:  Gregory L Holmes
Journal:  Paediatr Drugs       Date:  2020-04       Impact factor: 3.022

Review 5.  Lysosomal Stress Response (LSR): Physiological Importance and Pathological Relevance.

Authors:  Koffi L Lakpa; Nabab Khan; Zahra Afghah; Xuesong Chen; Jonathan D Geiger
Journal:  J Neuroimmune Pharmacol       Date:  2021-03-22       Impact factor: 4.147

6.  Stem Cell Applications in Lysosomal Storage Disorders: Progress and Ongoing Challenges.

Authors:  Sevil Köse; Fatima Aerts-Kaya; Duygu Uçkan Çetinkaya; Petek Korkusuz
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis.

Authors:  Brianna M Quinville; Natalie M Deschenes; Alex E Ryckman; Jagdeep S Walia
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

8.  Neu1 deficiency induces abnormal emotional behavior in zebrafish.

Authors:  Asami Ikeda; Mayu Komamizu; Akito Hayashi; Chiharu Yamasaki; Keiji Okada; Momoko Kawabe; Masaharu Komatsu; Kazuhiro Shiozaki
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

Review 9.  Autophagy: A Friend or Foe in Allergic Asthma?

Authors:  Efthymia Theofani; Georgina Xanthou
Journal:  Int J Mol Sci       Date:  2021-06-12       Impact factor: 5.923

Review 10.  Novel Approaches of Dysregulating Lysosome Functions in Cancer Cells by Specific Drugs and Its Nanoformulations: A Smart Approach of Modern Therapeutics.

Authors:  Khaled S Allemailem; Ahmad Almatroudi; Faris Alrumaihi; Saleh A Almatroodi; Mohammad O Alkurbi; Ghaiyda Talal Basfar; Arshad Husain Rahmani; Amjad Ali Khan
Journal:  Int J Nanomedicine       Date:  2021-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.